Intramembrane proteolysis by presenilins

Nature Reviews Molecular Cell Biology

Volumn 1, Issue 3, 2000, Pages 217-224

  Steiner, Harald ^a   Haass, Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PRESENILIN 1; PRESENILIN 2; PROTEINASE; PSEN1 PROTEIN, HUMAN; PSEN2 PROTEIN, HUMAN; SECRETASE;

ALZHEIMER DISEASE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DEGENERATIVE DISEASE; GENETICS; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; ENDOPEPTIDASES; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MUTATION; NEURODEGENERATIVE DISEASES; PRESENILIN-1; PRESENILIN-2; SIGNAL TRANSDUCTION;

EID: 0034568802     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35043065     Document Type: Review

References (106)

1. Teplow, D. B. Structural and kinetic features of amyloid β-protein fibrillogenesis. Amyloid 5, 121-142 (1998).
2. Lansbury, P. T. Jr Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19, 1151-1154 (1997).
3. Yankner, B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932 (1995).
4. Haass, C. & Selkoe, D. J. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042 (1993).
5. Kang, J. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736 (1987).
6. Vassar, R. & Citron, M. Aβ-generating enyzmes: recent advances in β- and γ-secretase research. Neuron 27, 419-422 (2000).
7. Haass, C., Koo, E. H., Mellon, A., Hung, A. Y. & Selkoe, D. J. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503 (1992).
8. Perez, R. G., Squazzo, S. L & Koo, E. H. Enhanced release of amyloid β-protein from codon 670/671 'Swedish' mutant β-amyloid precursor protein occurs in both secretory and endocytic pathways. J. Biol. Chem. 271, 9100-9107 (1996).
9. Wolfe, M. S. et al. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry 38, 4720-4727 (1999).
10. Lichtenthaler, S. F. et al. Mechanism of the cleavage specif city of Alzheimer's disease γ-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc. Natl Acad. Sci. USA 96, 3053-3058 (1999).
11. Haass, C. et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325 (1992).
12. Busciglio, J., Gabuzda, D. H., Matsudaira, P. & Yankner. B. A. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl Acad. Sci. USA 90, 2092-2096 (1993).
13. Shoji, M. et al. Production of the Alzheimer amyloid β-protein by normal proteolytic processing. Science 258, 126-129 (1992).
14. Seubert, P. et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327 (1992).
15. Esch, F. S. et al. Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248, 1122-1124 (1990).
16. Lammich, S. et al. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Sci. USA 96, 3922-3927 (1999).
17. Buxbaum, J. D. et al. Evidence that tumor necrosis factor-α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767 (1998).
18. Primakoff, P. & Myles, D. G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16, 83-87 (2000).
19. Sisodia, S.S. β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl Acad. Sci. USA 89, 6075-6079 (1992).
20. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760 (1995).
21. Rogaev, E. I. et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778 (1995).
22. Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease focus. Science 269, 973-977 (1995).
23. Wisniewski, T. et al. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport 9, 217-221 (1998).
24. Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190 (1996). First demonstration that presenilins undergo endoproteolysis and occur as stable amino- and carboxy-terminal fragments in vivo.
25. Seeger, M. et al. Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc. Natl Acad. Sci. USA 94, 5090-5094 (1997).
26. Capell, A. et al. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J. Biol. Chem. 273, 3205-3211 (1998).
27. Yu, G. et al. The presenuin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J. Biol. Chem. 273, 16470-16475 (1998).
28. Thinakaran, G. et al. Stable association of presenilin derivatives and absence of presenilin interactions with APR Neurobiol. Dis. 4, 438-453 (1998).
29. Saura, C. A. et al. Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing. J. Biol. Chem. 274, 13818-13823 (1999).
30. Doan, A. et al. Protein topology of presenilin 1. Neuron 17, 1023-1030 (1996).
31. Li, X. & Greenwald, I. Membrane topology of the C. elegans SEL-12 presenilin. Neuron 17, 1015-1021 (1996).
32. Li, X. & Greenwald, I. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proc. Natl Acad. Sci. USA 95, 7109-7114 (1998).
33. Lehmann, S., Chiesa, R & Harris, D. A. Evidence for a six-transmembrane domain structure of presenilin 1. J. Biol. Chem. 272, 12047-12051 (1997).
34. Nakai, T. et al. Membrane topology of Alzheimer's disease-related presenilin 1. Evidence for the existence of a molecular species with a seven membrane-spanning and one membrane-embedded structure. J. Biol. Chem. 274, 23647-23658 (1999).
35. Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996). Familial Alzheimer's disease-linked mutations of PS1 and PS2 enhance Aβ42 production in vivo.
36. Selkoe, D. J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-A31 (1999).
37. Price, D. L, Tanzi, R. E., Borchelt, D. R. & Sisodia, S. S. Alzheimer's disease: genetic studies and transgenic models. Annu. Rev. Genet 32, 461-193 (1998).
38. Conlon, R. A., Reaume, A. G. S Rossant, J. Notch1 is required for tne coordinate segmentation of somites. Development 121, 1533-1545 (1995).
39. Mumm, J. S. & Kopan, R. Notch signaling: From the outside in. Dev. Biol. On the press).
40. Wong, P. C. et al. Presenilin 1 is required for Notch 1 and DII1 expression in the paraxial mesoderm. Nature 387, 288-292 (1997).
41. Shen, J. et al. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639 (1997).
42. Herreman, A. et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA 96, 11872-11877 (1999).
43. Donoviel, D. B. et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801-2810 (1999).
44. Levitan, D. & Greenwald, I. Facilitation of lin-72-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354 (1995).
45. Levitan, D. et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 93, 14940-14944 (1996).
46. Baumeister, R. et al. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct. 1, 149-159 (1997).
47. Steiner, H. et al. A loss of function mutation of preseniln-2 interferes with amyloid β-peptide production and Notch signaling. J. Biol. Chem. 274, 28669-28673 (1999).
48. Capell, A. et al. Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch. Nature Cell Biol. 2, 205-211 (2000).
49. Wittenburg, N. et al. Presenilin is required for proper morphology and function of neurons in C. elegans. Nature 406, 306-309 (2000).
50. Ye, Y., Lukinova, N. & Fortini, M. E. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398, 525-529 (1999).
51. Struhl, G. & Greenwald, I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398, 522-525 (1999).
52. De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390 (1998). Pioneering work showing that PS1-knockout cells are deficient In γ-secretase cleavage of βAPP.
53. Schroeter, E. H., Kisslinger, J. A. & Kopan, R. Notch-1 signalling requires ligand-induced proteofytic release of intracellular domain. Nature 393, 382-386 (1998).
54. Struhl, G. & Adachi, A. Nuclear access and action of Notch in vivo. Cell 93, 649-660 (1998).
55. Huppert, S. S. et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966-970 (2000).
56. De Strooper, B. et al. A presenilin-1 -dependent γ-secretase-like protease mediates release of Notch intracellar domain. Nature 398, 518-522 (1999). PS1 deficiency as well as γ-secretase inhibitors block the γ-secretase-like cleavage of Notch.
57. Song, W. et al. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl Acad. Sci. USA 96, 6959-6963 (1999).
58. Zhang, Z. et al. Presenilins are required for γ-secretase cleavage of βAPP and transmembrane cleavage of Notch-1. Nature Cell Biol. 2, 463-465 (2000).
59. Herreman, A. et al. Total inactivation of β-secretase activity in presenilin-deficient embryonic stem cells. Nature Cell Biol. 2, 461-462 (2000).
60. Logeat, F. et al. The Notch1 receptor is cleaved constitutivety by a furin-like convertase. Proc. Natl Acad. Sci. USA 95, 8108-8112 (1998).
61. Mumm, J. S. et al. A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch1. Mol. Cell 5, 197-206 (2000).
62. Brou, C. et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207-216 (2000).
63. Naruse, S. et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213-1221 (1998).
64. Shearman, M. S. et al. L-685,458, an aspartyt protease transition state mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity. Biochemistry 39, 8698-8704 (2000).
65. Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513-517 (1999). Mutational analysis of two conserved aspartates within TM6 and TM7 indicates that presenilins may be unusual aspartyl proteases identical with γ-secretase.
66. Xia, W. et al. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation. Proc. Natl Acad. Sci. USA 97, 9299-9304 (2000).
67. Kimberly, W. T., Xia, W., Rahmati, T. Wolfe, M. S. & Selkoe, D. J. The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation. J. Biol. Chem. 275, 3173-3178 (2000).
68. Leimer, U. et al. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid β-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 38, 13602-13609 (1999).
69. Ray, W. J. et al. Cell surface presenilin-1 participates in the γ-secretase-like proteolysis of Notch. J. Biol. Chem. 274, 36801-36807 (1999).
70. Brockhaus, M. et al. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and Notch signaling. Neuroreport 9, 1481-1486 (1998).
71. Steiner, H. et al. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J. Biol. Chem. 273, 32322-32331 (1998).
72. Tomita, T. et al. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid β-peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Aβ42. J. Biol. Chem. 273, 21153-21160 (1998).
73. Citron, M. et al. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid β-protein. Neurobiol. Disord. 5, 107-116 (1998).
74. Li, Y.-M. et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689-694 (2000).
75. Esler, W. P. et al. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1. Nature Cell Biol. 2, 428-433 (2000). References 74 and 75 show that transition-state analogue inhibitors bind to preseniuns, indicating that presenilins may contain the active site of γ-secretase.
76. Steiner, H. et al. Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis. Biochemistry 38, 14600-14605 (1999).
77. Jacobsen, H. et al. The influence of endoproteolytic processing of familial Alzheimer's disease presenilin 2 on Aγ42 amyloid peptide formation. J. Biol. Chem. 274, 35233-35239 (1999).
78. Li, Y.-M. et al. Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state. Proc. Natl Acad. Sci. USA 97, 6138-6143 (2000). Identification of nicastrin, a component of the presenilin complex that modulates γ-secretase activity.
79. Yu, G. et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature 407, 48-54 (2000).
80. Cruts, M. et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4, 2363-2371 (1995).
81. Tanahashi, H. et al. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients. Neurosci. Lett. 218, 139-141 (1996).
82. De Jonghe, C. et al. Evidence that Aβ42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. Neurobiol. Disord. 6, 280-287 (1999).
83. Steiner, H. et al. Glycine 384 is required for presenilin-1 function and is conserved in polytopic bacterial aspartyl proteases. Nature Cell Biol. 2, 848-851 (2000). Presenilins share sequence homology around an active site aspartate with polytopic bacterial aspartyl proteases.
84. Steiner, H. et al. The biological and pathological function of the presenilin-1 Δexon 9 mutation is independent of its defect to undergo proteolytic processing. J. Biol. Chem. 274, 7615-7618 (1999).
85. LaPointe, C. F. & Taylor, R. K. The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases. J. Biol. Chem. 275, 1502-1510 (2000).
86. Brown, M. S., Ye, J., Rawson, R. B. & Goldstein, J. L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398 (2000).
87. Sinha, S. et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537-540 (1999).
88. Wolfe, M. S. et al. A substrate-based difluoroketone selectively inhibits Alzheimer's γ-secretase activity. J. Med. Chem. 41, 6-9 (1998).
89. Qiu, W. Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J. Biol. Chem. 273, 32730-32738 (1998).
90. Vekrellis, K. et al. Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20, 1657-1665 (2000).
91. Iwata, N. et al. Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nature Med. 6, 143-150 (2000).
92. Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999).
93. Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6, 916-919 (2000).
94. Struhl, G. & Adachi, A. Requirements for presenilin-dependent cleavage of Notch and other transmembrane proteins. Mol. Cell 6, 625-636 (2000). Presenilins may have a general role in endoproteolysis of transmembrane domains of type I transmembrane proteins, which undergo ectodomain shedding.
95. Suzuki, N. et al. An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (β-APP717) mutants. Science 264, 1336-1340 (1994).
96. Iwatsubo, T. et al. Visualization of Aβ-42(43) and Aβ-40 in senile plaques with end-specific Aβ-monoclonals: evidence that an initially deposited species is Aβ-42(43). Neuron 13, 45-53 (1994).
97. Annaert, W. G. et al. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell Biol. 147, 277-294 (1999).
98. Lah, J. J. & Levey, A. I. Endogenous presenilin-1 targets to endocytic rather than biosynthetic compartments. Mol. Cell. Neurosci. 16, 111-126 (2000).
99. Kulic, L. et al. Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch. Proc. Natl Acad. Sci. USA 97, 5913-5918 (2000).
100. Mori, K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101, 451-454 (2000).
101. Sato, N. et al. Upregulation of BiP and CHOP by the unfolded protein response is independent of presenilin expression. Nature Cell Biol. 2, 863-870 (2000).
102. Niwa, M., Sidrauski, C., Kaufman, R. J. & Walter, P. A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response. Cell 99, 691-702 (1999).
103. Katayama, T. et al. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nature Cell Biol. 1, 479-485 (1999).
104. Wolozin, B. et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713 (1996).
105. Kim, T. W., Pettingell, W. H., Jung, Y. K., Kovacs, D. M. & Tanzi, R. E. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376 (1997).
106. Yoo, A. S. et al. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27, 561-572 (2000).